Target intelligence / Profile preview

Novel transcript, antisense to DET1 (ENSG00000305611)

Target
ENSG00000305611
Molecular classification
Other, natural antisense transcript (NAT), long non-coding RNA (lncRNA)
01

Overview

"Novel transcript, antisense to DET1" (ENSG00000305611/LOC124903547) is currently annotated as a long non-coding RNA (lncRNA) that is transcribed antisense to the DET1 gene. Natural antisense transcripts (NATs) are a widespread class of RNAs found throughout eukaryotic genomes and can regulate the expression of their sense-strand counterparts via mechanisms such as transcriptional interference, RNA editing, or chromatin modification[3][1]. The specific biological function and disease relevance of this transcript remain uncharacterized, and it is not established as a therapeutic target. Its role is likely in modulating DET1 gene expression, but the details have not been experimentally defined in literature or major genomics repositories. This transcript is cataloged as a natural antisense RNA with no current evidence for therapeutic targeting or disease involvement; it is not a receptor, enzyme, or typical drug target class, and little functional information is available[3][1].

Other names
LOC124903547ENSG00000305611novel transcript antisense to DET1
02

Mechanism of action

No characterized mechanism of action for this transcript as a drug target.

03

Biological functions

OtherModulate gene expression of sense counterpartsInfluence chromatin structureSense transcript stability modulationProcessing modulation
04

Disease associations

OtherNo established disease associations for this specific transcript. Antisense RNAs may play roles in gene regulation involved in various diseases, but specific data for this locus is lacking.
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Novel transcript, antisense to DET1 (ENSG00000305611).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to DET1 (ENSG00000305611).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call